Janux Therapeutics JANX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Janux Therapeutics's enterprise value?
- Janux Therapeutics (JANX) reported enterprise value of $815.3M in Q1 2026.
- How has Janux Therapeutics's enterprise value changed year-over-year?
- Janux Therapeutics's enterprise value decreased by 47.2% year-over-year, from $1.54B to $815.3M.
- What is the long-term trend for Janux Therapeutics's enterprise value?
- Over 4 years (2021 to 2025), Janux Therapeutics's enterprise value has grown at a 0.6% compound annual growth rate (CAGR), from $779.77M to $799.84M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.